Some Trilogy 100/200 and V60/V60 Plus users impacted by Philips Respironics recalls may be using the Trilogy Evo platform of ventilators as an alternative. Please be aware of recent important product updates related to the Trilogy Evo platform of devices. Please note, when the mitigating actions specified in the Field Safety Notices are taken:
- Trilogy Evo continues to be an alternative for Trilogy 100 and Trilogy 200 devices impacted by the June 2021 recall of certain CPAP, BiPAP and mechanical ventilators related to PE-PUR sound abatement foam
- The Trilogy EV300 continues to be an alternative for Philips Respironics V60 and V60 Plus devices impacted by an issue related to the power management PC board
- The Trilogy Evo platform continues to be an alternative for new patients needing treatment
For more information on field safety notices related to the Trilogy Evo platform of ventilators, please click here.
